HCPCS code J9227 — Inj. isatuximab-irfc 10 mg. Status: Active. Effective Oct 1, 2020. Source: CMS HCPCS Level II.

J9227

Active

Inj. isatuximab-irfc 10 mg

Injection, isatuximab-irfc, 10 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Oct 1, 2020
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9377

MUE — Medically Unlikely Edits

Maximum units of J9227 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 150
Practitioner Services 150

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
00024-0654-01 Sarclisa
00024-0656-01 Sarclisa

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2020-Q4
    Inj. isatuximab-irfc 10 mg